Market Cap: $49.28B
Market Cap: $49.28B

Teva Pharmaceutical Industries Limited ( TEVA ) is undergoing a transformative phase that marks a significant departure from its previous struggles in the generic drugs market. With a strategic pivot…

Teva Pharmaceutical Industries (Ticker: TEVA) makes headlines with its recent filing for ecopipam, a groundbreaking treatment for pediatric Tourette syndrome. This New Drug Application (NDA) has been…

Teva Pharmaceutical Industries (Ticker: TEVA) embarks on a significant advancement in its product offerings with the launch of AHZANTIVE, a novel biosimilar designed for the treatment of retinal condi…

Teva Pharmaceutical Industries (Ticker: TEVA) announces important findings from its IMPACT-TD Registry that spans three years, focusing on tardive dyskinesia (TD). This research is particularly releva…

Teva Pharmaceutical Industries (Ticker: TEVA) demonstrates a commitment to addressing mental health disorders among young adults through its recent presentation at the American Psychiatric Association…

Teva Pharmaceutical Industries launches the Home Ground Schizophrenia Community, an online platform that offers crucial support and resources for individuals affected by schizophrenia and their caregi…

Teva Pharmaceutical Industries launches the Home Ground Schizophrenia Community, an innovative online platform aimed at supporting individuals living with schizophrenia and their caregivers. The platf…

Teva Pharmaceutical Industries is experiencing significant progress in the biosimilar market following recent regulatory advancements. The U.S. Food and Drug Administration (FDA) has granted approval…
Teva Pharmaceutical's Evolving Market Sentiment: A Decrease in Short Interest Recent data reveals a notable decline in the short interest of Teva Pharmaceutical Industries Ltd., illustrating a signifi…
Teva Pharmaceutical Industries Sees Shift in Market Sentiment Teva Pharmaceutical Industries Ltd. experiences a notable decrease in short interest, signaling a shift in market sentiment towards the co…
Teva Pharmaceutical’s Olanzapine Extended-Release Injection Moves to Full FDA Review Teva Pharmaceutical Industries Ltd. has achieved a significant milestone with the recent acceptance of its New Drug…
Teva Pharma Advances Olanzapine Injectable Suspension Towards FDA Approval Teva Pharmaceutical Industries Ltd. captures attention as it announces that the U.S. Food and Drug Administration (FDA) has a…
Teva Pharmaceutical Industries: Navigating Through Operational Dynamics and Market Sentiment Teva Pharmaceutical Industries Inc. stands at a pivotal juncture as it continues to make significant stride…
### Teva's Generic Korlym Labeling Sparks Intellectual Property Dispute Teva Pharmaceutical Industries faces a significant challenge regarding the proposed labeling for its generic version of Korlym,…
Teva faces legal fight over Korlym generic labeling Teva Pharmaceutical Industries is defending a challenge from Corcept Therapeutics over the proposed label for Teva’s generic version of Korlym, a dr…
Korlym generic label dispute centers on inducement claim Teva Pharmaceutical is facing a legal and regulatory fight over the label it proposes for a generic version of Korlym, the mifepristone therapy…
Korlym Labeling Battle Puts Teva’s Generic Launch Under Legal Scrutiny Corcept Therapeutics contends Teva Pharmaceutical is seeking approval for a generic version of Korlym with labeling that would in…
Analysts Spotlight on Pharma's Resurgence Teva Pharmaceutical Industries draws fresh attention from Wall Street as Goldman Sachs highlights a substantive change in the company's operating outlook. The…
Teva Pharmaceutical Industries Strengthens Financial Standing with Credit Rating Upgrades Teva Pharmaceutical Industries Ltd. receives a boost in its financial reputation as S&P Global Ratings upgrade…
Teva Pharmaceutical Industries: A Shift in Investor Sentiment Fuels Confidence in Future Growth Teva Pharmaceutical Industries experiences a significant transformation in investor sentiment as large i…
Whale Investors Signal Confidence in Teva Pharmaceutical's Future Teva Pharmaceutical Industries finds itself at a critical juncture as large investors, often referred to as "whales," demonstrate a re…
Teva Pharmaceutical Faces Rising Short Interest Amid Market Speculation Teva Pharmaceutical Industries Ltd, a significant player in the global pharmaceutical market, currently experiences a notable ri…
Teva Pharmaceutical Faces Heightened Short Interest Amid Market Speculation Teva Pharmaceutical Industries Ltd is currently experiencing a notable increase in its short interest, which has risen by 6.…
Telehealth Ethics at a Crossroads: The Case of Done Global A recent federal jury conviction of Ruthia He, founder of the telehealth startup Done Global, highlights pressing ethical concerns within the…
Telehealth Under Scrutiny: Ethical Responsibilities and Patient Safety A recent jury verdict against Ruthia He, founder of the telehealth startup Done Global, highlights significant ethical concerns w…
Teva Pharmaceutical Faces Internal Scrutiny Following Insider Sell-Off Teva Pharmaceutical Industries is currently under the spotlight following a notable insider transaction reported by the company.…
Teva Pharmaceutical Industries: Navigating Shareholder Confidence Amidst Growth Teva Pharmaceutical Industries Inc. stands at a pivotal moment as it experiences significant growth in its stock perform…
Teva Pharmaceuticals: Navigating Growth and Valuation Concerns in the Pharmaceutical Industry Teva Pharmaceutical Industries Inc. continues to experience notable growth, reflecting a strong position w…
Teva Pharmaceutical's Strong Third Quarter Performance Signals Strategic Growth Teva Pharmaceutical Industries Ltd. recently reports its financial results for the third quarter of 2025, showcasing a t…
SciSparc's Strategic Acquisition: A Shift in the Biotech Landscape SciSparc Ltd. solidifies its position in the pharmaceutical and biotechnology sectors with a definitive agreement to acquire a contro…
Teva Pharmaceutical Industries: Potential Tariff Exemption for Generic Drugs Could Reshape Market Dynamics Teva Pharmaceutical Industries stands at a critical juncture as the Trump administration cons…
Significant Policy Change on Tariffs for Generic Drugs Could Reshape Pharmaceutical Landscape Teva Pharmaceutical Industries stands at the forefront of a potential transformative shift in the pharmace…
Teva Pharmaceutical Industries: Navigating Growth Opportunities Amid Industry Transformations Teva Pharmaceutical Industries is at a crucial juncture as the pharmaceutical industry continues to evolve…
Teva Pharmaceuticals: Navigating Strategic Realignment Amid Industry Challenges Teva Pharmaceutical Industries finds itself in an environment fraught with challenges and opportunities as the pharmaceu…
Teva Pharmaceutical Industries: Renewed Investor Confidence Amid Strategic Transformation Teva Pharmaceutical Industries is experiencing a notable shift in investor sentiment, as significant capital p…
New Initiatives on Drug Safety and Autism: A Critical Step for Public Health Teva Pharmaceutical Industries, a global leader in generic and specialty medicines, is poised to be impacted by the upcomin…
Teva Pharmaceuticals Champions Affordable Healthcare Through New Generic Drug Initiatives Teva Pharmaceutical Industries is at the forefront of a significant shift within the pharmaceutical industry t…
Generic Drug Development Highlights Teva's Commitment to Affordable Healthcare Teva Pharmaceutical Industries is at the forefront of a significant shift within the pharmaceutical industry as the deman…
Shifting Sentiment in Teva Pharmaceutical Industries Reflects Positive Market Dynamics Teva Pharmaceutical Industries is currently experiencing a notable shift in market sentiment, as indicated by a s…
Teva Pharmaceutical Industries Sees Shift in Trader Sentiment Teva Pharmaceutical Industries is currently experiencing a notable shift in market sentiment as indicated by a significant decrease in its…
Teva Pharmaceutical Industries Prepares for Key Earnings Report Amidst Industry Challenges Teva Pharmaceutical Industries Ltd. is on the brink of releasing its financial results for the second quarter…
Teva Pharmaceutical Faces Rising Short Interest Amid Market Uncertainty Teva Pharmaceutical Industries is currently grappling with heightened bearish sentiment among investors, as evidenced by a signi…
Teva Pharmaceutical Industries Faces Increased Short Interest Amid Market Uncertainty Teva Pharmaceutical Industries, a global leader in generic and specialty pharmaceuticals, experiences a notable ri…
Evolving Perspectives on Teva Pharmaceutical Industries' Market Position Teva Pharmaceutical Industries faces a multifaceted outlook as recent analyst ratings reveal a spectrum of opinions regarding t…
Teva Pharmaceutical's Analyst Ratings Reflect Diverse Industry Perspectives Teva Pharmaceutical Industries finds itself amidst a complex landscape, as evidenced by the varied ratings issued by five an…
Teva Pharmaceuticals Partners with Fosun Pharma to Advance Innovative Cancer Therapy Teva Pharmaceutical Industries Ltd. announces a strategic partnership with Shanghai Fosun Pharmaceutical (Group) Co…
Teva and Fosun Pharma Forge Strategic Alliance in Oncology Development Teva Pharmaceutical Industries Ltd. has announced a strategic partnership with Shanghai Fosun Pharmaceutical Group to expedite th…
Teva Pharmaceutical Industries: Positioned for Growth in the Generic Pharmaceuticals Sector Teva Pharmaceutical Industries finds itself at the forefront of a burgeoning market as Goldman Sachs initiat…
Teva Pharmaceutical Industries Faces Rising Short Interest Amid Market Skepticism Teva Pharmaceutical Industries Ltd., a prominent player in the global pharmaceutical market, currently navigates a cha…
Teva Pharmaceutical Faces Rising Short Interest Amid Market Skepticism Teva Pharmaceutical Industries, a key player in the global pharmaceutical market, currently grapples with a notable increase in i…